GLP-1 Medications - MyConciergeMD

Did you know that GLP-1 medications don’t only help manage blood sugar levels, but some can also help with weight loss. If you’re struggling with weight loss and need some extra push to facilitate weight loss, Glucagon-like peptide 1 also known as (GLP-1 agonists) can help.

GLP-1 drugs are in a class of medications called Semaglutides. These medications include Liraglutide, Exenatide, Albiglutide, Ozempic, Exenatide, Rybelsus, Dulaglutide, Lixisenatide, Bydureon and Byetta. GLP 1 agonists can be the perfect solution for your weight loss needs. At My Concierge MD, we provide compounded forms of these diabetes injections for weight loss as well have relationship with the best pharmacies to get them for you.

Let’s talk about what GLP-1 medications are, how they work, and why they are good for weight loss.

What are GLP-1 drugs?

GLP-1 agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with Type 2 diabetes [1]. Some GLP-1 agonists can also help treat obesity. GLP-1 agonists are most often injectable medications, meaning you inject a liquid medication with a needle and syringe. The only GLP-1 medication that is oral and taken by mouth at the moment is Rybelsus.

How do GLP-1 drugs work?

GLP-1 agonists mimic the action of GLP-1 hormone.  They work by stimulating insulin production, inhibiting glucagon release, and slowing insulin absorption by reducing the speed of stomach emptying.


Side effects of GLP-1 drugs

  • Loss of appetite
  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
  • Bloating
  • Indigestion
  • Headache
  • Redness, itching, or soreness of the skin at the injection site

Side effects of GLP-1 drugs - MyConciergeMDRole of GLP-1 medications for weight loss

GLP agonists can now be used for the treatment of obesity, thanks to their effectiveness. FDA approved Liraglutide as a weight loss drug. Semaglutide’s results on weight loss look promising compared to Liraglutide.

Due to their effectiveness in body weight management, liraglutide 3mg/day and semaglutide 2.4mg/week are approved for obesity treatment [2].

What is the best GLP-1 drugs for weight loss?

FDA approved two GLP-1 agonists, Wegovy and Saxenda, as of now. Both of these drugs have successfully shown weight loss in people with obesity who do not have diabetes. In clinical studies, semaglutide has shown significant weight loss when compared with the effects of liraglutide. The study found that participants on semaglutide plus diet and exercise saw a 9.4% greater average loss in baseline weight compared with those on liraglutide [3].

Is metformin a GLP-1 drug?

No, metformin isn’t a GLP-1 drug. It belongs to a class of drug called biguanides and works at lowering glucose levels produced by the liver and improving insulin sensitivity [4].

What are the brand names of GLP-1 agonists?

  • Adlyxin (lixisenatide)
  • Bydureon (exenatide ER)
  • Byetta (exenatide)
  • Ozempic (semaglutide)
  • Trulicity (dulaglutide)
  • Victoza (liraglutide)

Please note that this is not a complete list, and there may be other brand names available in different countries as well.

Contact us at 310-299-8959 to schedule an in office consult or virtual consult or

Book Online to receive your prescription of Wegovy or other Semaglutide or Trizepatide for weight loss.

  • Virtual Consult with MD & Nutritionist $450
  • 3 Month Supply of the best compounded semaglutide injection  $750 ( Special Pricing) 
  • Total cost for 3 month supply of injections for weight loss, consultation with Medical Doctor & Nutritionist $1200 (Special Pricing) 
  • Follow Ups every 3 months there after $250 plus cost of medication. 
  • Lose 10 – 20% of body fat safely and effectively! 
  • Pick up medication from our Beverly Hills office or have it shipped to you 
  • Our nursing staff and team will follow up with you to make sure you are doing well and losing weight without unwanted side effects. 

Which GLP-1 agonist is the cheapest?

Keeping the price list of in mind, Trulicity (dulaglutide) is the most cheapest ones out of all the others. Here’s the price list for the agonists:

  • Byetta (exenatide) – $1,200
  • Bydureon (exenatide ER) – $1,500
  • Adlyxin (lixisenatide) – $1,500
  • Victoza (liraglutide) – $1,160
  • Trulicity (dulaglutide) – $968
  • Ozempic (semaglutide) – $973
  • Saxenda (liraglutide) – $1,302
  • Wegovy (semaglutide) – $1,302

The prices of the agonists can change depending on various considerations. So, it’s best to consult your doctor.

Buy GLP-1 Drugs Online

Contact us at 310-299-8959 to schedule an in office consult or virtual consult and receive the best compounded GLP-1 receptor agonist delivered to your door for a fraction of the cost of the brand name.

Book Online to receive your 3 month supply of compounded medication or have the brand name prescription of Wegovy or other Semaglutide or Tirzepatide for weight loss called into your local pharmacy.

Receive Semaglutide Injections for weight loss

  • Virtual Consult with MD & Nutritionist $450
  • 3 Month Supply of the best compounded Semaglutide injection  $800 ( Special Pricing) 
  • Follow Ups $250
  • Lose 10 – 20% of body fat safely and effectively

Receive Tirzepatide Injections for weight loss

  • Virtual Consult with MD & Nutritionist $450
  • 1 Month Supply of the best compounded Tirzepatide injection  $800 ( Special Pricing) 
  • Follow Ups $250
  • Lose 10 – 20% of body fat safely and effectively


Is GLP-1 better than metformin?

A study published in the journal Diabetes Care compared the efficacy of the agonists with metformin for type 2 diabetes treatment. They found that GLP-1 receptor agonists were more effective than metformin in lowering body weight and HbA1c levels. With that said, metformin is still considered the primary medication for type 2 diabetes treatment and GLP-1 agonists come as the secondary treatment [5].

Which GLP-1 is taken daily?

It is best to talk to your doctor first about the medication; you may have unique requirements for depending on your health condition. With that said, some GLP-1 can be taken once daily, while others are taken twice a day or once a week. Drugs like Victoza (liraglutide) is taken once daily and Byetta (exenatide) is taken twice daily.

What is the newest GLP-1 drug?

FDA approved Zepbound (tirzepatide) on November 8, 2023. The drug was approved for its benefits against weight loss in obese adults. Zepbound is made by Eli Lilly and Company, the same company that made Mounjaro.

GLP-1 Medications Near Me

MyconciergeMD offers the best hormonal acne treatment near me in Beverly Hills but can also come to your home or office throughout the Los Angeles area. We serve patients near Beverly Hills, Bel Air, West Hollywood, Santa Monica, West Los Angeles, Culver City, Hollywood, Venice, Marina del Rey, Malibu, Manhattan Beach, Redondo Beach, Downtown Los Angeles, Encino, Woodland Hills, Sherman Oaks, Calabasas, Burbank, Glendale, Hidden Hills, Agoura Hills, Northridge, North Hollywood, Topanga, Canoga Park, Reseda, Valley Glen, Chatsworth, West Hills, Winnetka, Universal City, Silverlake, Echo Park, and many more.


  1. Collins L, Costello RA. Glucagon-Like Peptide-1 Receptor Agonists. [Updated 2023 Jan 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from:
  2. Ard J, Fitch A, Fruh S, Herman L. Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Receptor Agonists. Adv Ther. 2021 Jun;38(6):2821-2839. doi: 10.1007/s12325-021-01710-0. Epub 2021 May 11. PMID: 33977495; PMCID: PMC8189979.
  3. Rubino DM, Greenway FL, Khalid U, et al. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA. 2022;327(2):138–150. doi:10.1001/jama.2021.23619
  4. Edoardo Mannucci, Agostino Ognibene, Francesco Cremasco, Gianluca Bardini, Antonella Mencucci, Enrica Pierazzuoli, Silvia Ciani, Gianni Messeri, Carlo M. Rotella; Effect of Metformin on Glucagon-Like Peptide 1 (GLP-1) and Leptin Levels in Obese Nondiabetic Subjects. Diabetes Care 1 March 2001; 24 (3): 489–494.
  5. Muhammad Abdul-Ghani, Ralph A. DeFronzo; Is It Time to Change the Type 2 Diabetes Treatment Paradigm? Yes! GLP-1 RAs Should Replace Metformin in the Type 2 Diabetes Algorithm. Diabetes Care 1 August 2017; 40 (8): 1121–1127.

As Seen On


As Featured on Extra TV